Literature DB >> 10420060

Epidemiology of post-stroke dementia.

F van Kooten1, P J Koudstaal.   

Abstract

Twenty to 25% of stroke patients are demented after stroke, which makes stroke an important risk factor for dementia. However, the diagnosis of dementia is difficult and depends heavily on methodology. In this review, we describe pitfalls of diagnosis, the prevalence and incidence of dementia after stroke based on data from prospectively studied stroke cohorts, and the risk factors for post-stroke dementia that emerged from these studies. Finally, the course and prognosis of post-stroke dementia are described.

Entities:  

Mesh:

Year:  1998        PMID: 10420060     DOI: 10.1159/000022424

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  6 in total

1.  Age-Induced Alterations in Hippocampal Function and Metabolism.

Authors:  Pavan K Shetty; Francesca Galeffi; Dennis A Turner
Journal:  Aging Dis       Date:  2011-06       Impact factor: 6.745

2.  Treatment of Vascular Cognitive Impairment.

Authors:  Aaron Ritter; Jagan A Pillai
Journal:  Curr Treat Options Neurol       Date:  2015-08       Impact factor: 3.598

3.  Charlson Comorbidity Index, inappropriate medication use and cognitive impairment : Bermuda Triangle.

Authors:  Kamile Silay; Ahmet Yalcin; Sema Akinci; Fatma Gul Gursoy; Didem Sener Dede
Journal:  Wien Klin Wochenschr       Date:  2017-09-01       Impact factor: 1.704

Review 4.  Dementia and cognitive impairment: epidemiology, diagnosis, and treatment.

Authors:  Julie Hugo; Mary Ganguli
Journal:  Clin Geriatr Med       Date:  2014-06-12       Impact factor: 3.076

5.  Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's disorders?

Authors:  Moussa B H Youdim
Journal:  Rambam Maimonides Med J       Date:  2010-10-31

6.  Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's diseases as disease modifying agents.

Authors:  Moussa B H Youdim
Journal:  Exp Neurobiol       Date:  2010-06-30       Impact factor: 3.261

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.